<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
<url><loc>https://healthcarenews.io/news/generic-nexletol-2040-seventh-settlement/</loc><news:news><news:publication><news:name>Healthcare News</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-11T15:24:52.272Z</news:publication_date><news:title>Generic Nexletol and Nexlizet: a seventh drugmaker agrees to wait until 2040</news:title></news:news></url>
<url><loc>https://healthcarenews.io/news/surgery-center-equipment-maintenance-trimedx-nationwide/</loc><news:news><news:publication><news:name>Healthcare News</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-11T12:25:05.018Z</news:publication_date><news:title>Medicare counted 6,436 surgery centers in 2024. Trimedx now offers them equipment maintenance nationwide</news:title></news:news></url>
<url><loc>https://healthcarenews.io/news/2026-access-to-medicine-index-novartis-ranks-first/</loc><news:news><news:publication><news:name>Healthcare News</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-11T05:36:51.320Z</news:publication_date><news:title>Novartis again leads drugmakers on reaching patients in poorer countries in the 2026 Access to Medicine Index</news:title></news:news></url>
<url><loc>https://healthcarenews.io/news/glanzmann-thrombasthenia-treatment-weekly-injection-phase-3/</loc><news:news><news:publication><news:name>Healthcare News</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-11-11T02:10:16.867Z</news:publication_date><news:title>Glanzmann thrombasthenia has no approved preventive treatment. A weekly injection enters its final-stage trial</news:title></news:news></url>
</urlset>
